Basic Information
ID: ALA3537498
Type: ADME
Description: Activity of recombinant human CYP2C19 expressed in Saccharomyces cerevisiae AH22 cells assessed as enzyme-mediated compound formation treated with episesamin at 2 to 75 uM after 15 mins by HPLC analysis in presence of NADPH
Format: BAO_0000219
Organism: Homo sapiens
Cell type: AH22
Target: Cytochrome P450 2C19(ALA3622)
Document: ALA3525932
Activity of recombinant human CYP2C19 expressed in Saccharomyces cerevisiae AH22 cells assessed as enzyme-mediated compound formation treated with episesamin at 2 to 75 uM after 15 mins by HPLC analysis in presence of NADPH: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA3537498
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 330.34 | 2.58 | 2.58 |
| 342.35 | 2.90 | 2.90 |
| 342.35 | 2.90 | 2.90 |